Koers China BCT Pharmacy Group, Inc. Other OTC
Aandelen
CNBI
US16890M1009
Farmaceutische producten
Omzet 2011 | 257 mln. 239 mln. | Omzet 2012 | 242 mln. 225 mln. | Marktkapitalisatie | 7,63 mln. 7,09 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2011 | 31 mln. 28,8 mln. | Nettowinst (verlies) 2012 | 21 mln. 19,51 mln. | EV/omzet 2011 | 0,18 x |
Nettoliquiditeiten 2011 | 21,95 mln. 20,39 mln. | Nettoschuld 2012 | 5,46 mln. 5,07 mln. | EV/omzet 2012 | 0,05 x |
K/w-verhouding 2011 |
2,47
x | K/w-verhouding 2012 |
0,48
x | Werknemers | - |
Dividendrendement 2011 * |
-
| Dividendrendement 2012 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hui Tian Tang
CEO | Chief Executive Officer | 62 | 30-12-09 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yun Li Lou
BRD | Director/Board Member | 56 | 18-01-11 |
Hui Tian Tang
CEO | Chief Executive Officer | 62 | 30-12-09 |
Kam Cheung Chin
BRD | Director/Board Member | 66 | 08-06-11 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,88% | 24,09 mld. | |
+7,11% | 8,2 mld. | |
-20,55% | 7,97 mld. | |
-2,59% | 7,84 mld. | |
+2,26% | 4,66 mld. | |
+17,12% | 4,32 mld. | |
+1,41% | 4,19 mld. | |
-3,02% | 3,89 mld. | |
+21,42% | 3,62 mld. |